Investigating the effect of blended in-person and on-line supportive care on quality of life of new cases of breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230119057155N2

Enrollment

Registered

2023-08-27

Start date

2023-08-06

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: People who have recently been diagnosed with breast cancer. They are informed that there are a number of support and care services in person. In-person services inc

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women newly diagnosed with breast cancer Oncology specialist referral No serious psychiatric illness No substance abuse or addiction

Exclusion criteria

Exclusion criteria: metastasis Participating in other treatment programs at the same time.

Design outcomes

Primary

Measure	Time frame
Hospital anxiety and depression. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: Hospital anxiety and depression scale(HADS).;Quality of life of patients. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: EORTC QLQ-C30.;Quality of life in breast cancer patients. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: (EORTC QLQ-BR23).;Supportive care needs. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: (SCNS).	—

Measure

Time frame

Hospital anxiety and depression. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: Hospital anxiety and depression scale(HADS).;Quality of life of patients. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: EORTC QLQ-C30.;Quality of life in breast cancer patients. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: (EORTC QLQ-BR23).;Supportive care needs. Timepoint: Before the intervention - after the intervention - 12 weeks after the intervention - 24 weeks after the intervention. Method of measurement: (SCNS).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHanieh Salimi Arshad Moghaddam

Esfahan University of Medical Sciences

salimimobina120@gmail.com0098 32371103

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026